Introduction {#s1}
============

Mother-to-child transmission (MTCT) of syphilis has been documented since the 15th century, yet, today, continues to cause substantial perinatal morbidity and mortality, even in developed countries, where antenatal health services are strong [@pone.0102203-Qin1]--[@pone.0102203-DeSantis1]. Prenatal screening coupled with appropriate, prompt penicillin treatment in prevention of MTCT of syphilis is feasible, inexpensive, and cost-effective, even in settings where the burden of syphilis among pregnant women is moderate or low [@pone.0102203-Hawkes1]--[@pone.0102203-Kuznik1]. Yet, despite the tools being available for over 60 y, MTCT of syphilis persists as a public health problem in many rural, urban, and suburban communities [@pone.0102203-Newman1]. In 2007, the World Health Organization (WHO) launched its initiative for Global Elimination of Congenital Syphilis (CS) as millennium development goals [@pone.0102203-World1]. In response to the call of the WHO, in June 2010, the China\'s Ministry of Health (MOH) officially launched the first national program specially and directly aimed at controlling syphilis and blocking MTCT of syphilis: the National Program for Prevention and Control of Syphilis in China (2010--2020) [@pone.0102203-China1]. In order to effectively eliminate of MTCT of syphilis and to guide policy and advocacy efforts, global data on the burden of syphilis in pregnancy and associated adverse pregnancy outcomes (APOs) are needed.

Currently, although some estimates for burden of syphilis in pregnancy and associated APOs were available, the global incidence of adverse birth outcomes among syphilitic women remains enough unclear. Over the years, some researchers have been trying to estimate the incidence of APOs resulting from maternal syphilis. For example, the latest meta-analysis by Gomez et al. [@pone.0102203-Gomez1] that is currently the only systematic review assessing this question indicated that approximately 52% of pregnancies in mothers with untreated or inadequately treated syphilis result in some APOs, with estimated proportions: early fetal loss or stillbirth (21%), neonatal death (9%), low birth weight or premature birth (6%), and infection in a live-born infant (15%), and among untreated pregnant women with syphilis, fetal loss and stillbirth were 21% more frequent, neonatal deaths were 9.3% more frequent and prematurity or low birth weight were 5.8% more frequent than among women without syphilis. However, this review didn\'t assess APOs under the background of different baseline titers and treatment time for maternal syphilis, and didn\'t include Chinese literatures. In China, there are large study reports to assess adverse outcomes among women with syphilis, while China\'s literatures are mainly local or single medical institution reports and only include the small sample size of study population, which causes that the findings are not comprehensive and meaningful representation of poor. Overall, most of previous estimates of APOs in women with syphilis have been based on point estimates from single studies.

Today, the full extent of MTCT of syphilis is difficult to measure because there is no definitive test for MTCT transmission; diagnosis based on clinical history and serologic testing in mothers and infants is often unavailable. Additionally, the countries where CS continues to be most problematic often lack even basic testing capacity, let alone more sophisticated laboratory techniques for diagnosis and staging syphilis during pregnancy. However, the large body of literatures from China, where syphilis testing is routinely done during pregnancy, can help address this issue. In order to support the global initiative for elimination of MTCT of syphilis, we conducted a systematic review and meta-analysis with the following objectives: (1) to estimate the APOs among syphilitic women according to baseline titers, treatment or not during pregnancy and gestational age at treatment; (2) to estimate APOs among women without syphilis; and (3) to provide scientific evidence for the prevention of pregnancy loss attributable to MTCT of syphilis.

Methods {#s2}
=======

Search strategy {#s2a}
---------------

PubMed, Cochrane Libraries, China Biology Medicine disc (CBMdisc), Chinese Scientific Journals Fulltext Database (CQVIP), China National Knowledge Infrastructure (CNKI) and Wanfang Data were searched through August 2013 with no restrictions to identify published peer-reviewed research articles assessing pregnancy outcomes in the presence of maternal syphilis by the following search terms: syphilis, pregnancy, adverse birth or pregnancy outcomes, congenital syphilis, preterm, low birth weight, stillbirth, fetal loss or death, abortion or miscarriage, neonatal death, and perinatal death or morbidity or mortality. We also performed a manual search on the reference lists of published articles. The grey literature and conference abstracts were not searched. This review was conducted and reported according to MOOSE guidelines and PRISMA requirements [@pone.0102203-Stroup1]--[@pone.0102203-Moher1].

Selection criteria {#s2b}
------------------

For those studies that not only reported the incidence of birth outcomes among syphilis-infected women, but also reported the incidence among non-syphilitic women, we will meanwhile estimate the range of possible birth outcomes among non-syphilitic women. Our APOs of interest were CS, preterm, low birth weight, stillbirth or early fetal loss, miscarriage and neonatal death. Studies were considered eligible for inclusion in this systematic review if they met the following criteria: (1) studies published in Chinese or English language; (2) studies described pregnancy outcomes among women presumed to have syphilis(i.e. women who were seroreactive for T. pallidum infection, irrespective of the test used); (3) study populations excluded HIV-positive women; (4) sample size for cases was more than 30 syphilitic patients; and (5) the incidences of APOs were reported(or data to calculate them). We excluded review papers, non peer--reviewed local/government reports, conference abstract and presentation in this study. If the same study data were published in both English and Chinese sources, the articles published in Chinese language were excluded from the review. We considered a broad range of study designs, including clinical trials, observational studies, and case series. We also assessed potential studies to ensure that there was no duplication of case series.

Data extraction {#s2c}
---------------

Two independent reviewers (JBQ and HLF) assessed eligibility criteria and extracted data, and any disagreements were resolved by discussion. We extracted the following information from all eligible studies: first author and published year; geographical location; study design; study period; syphilis prevalence among mothers; subgroup variables (infection status of syphilis, treatment or not for maternal syphilis, gestational age at treatment, and baseline titers of nontreponemal antibodies); sample size for cases and controls; reported adverse outcomes. Because variations in the definition of APOs exist across countries and cultures, it is extremely difficult to define uniform standards. The early literatures did not always define birth outcomes and in such cases we relied on the outcome terminology in the original papers.

Statistical analysis {#s2d}
--------------------

We calculated the combined incidence and the corresponding 95% confidence intervals (CI) for all APOs in women with syphilis and women without syphilis. We then also calculated the summary incidence and the corresponding 95%CI for the following selected pregnancy loss. The subgroup analysis for all APOs and specific APOs was performed based on whether women were infected with syphilis, whether syphilitic women were treated during pregnancy (i.e. syphilitic women receiving at least one injection of 2.4 million units of penicillin before delivery), gestational week at treatment (i.e. \<12 or 12 to 28 or ≥28 weeks), and maternal baseline titers (i.e. ≥1∶8 *or* \<1∶8) to explore the sources of heterogeneity.

The combined incidence and the corresponding 95% CI were calculated using either fixed-effects models or, in the presence of heterogeneity, random-effects models. Heterogeneity tests were performed using the Cochran Q-test (p\<0.10 represents statistically significant heterogeneity) and I^2^ statistic. Begg\'s rank correlation test was used to assess publication bias (p\<0.10 represents statistical significance). The chi-square test was used to analyze the difference between subgroups (p\<0.05 represents statistical significance). The comparison between subgroups was performed using SAS version 9.1, and other data were prepared and analyzed using R software version 3.0.

Results {#s3}
=======

Study characteristics {#s3a}
---------------------

Our initial search criteria identified 4149 articles from six electronic databases and 38 additional articles were identified through reference lists from identified articles. Of these, the majority were excluded after the first screening based on abstracts or titles, mainly because they were review papers, and unrelated to the topics or duplicated titles from different databases ([Figure 1](#pone-0102203-g001){ref-type="fig"}). Finally, fifty-four studies [@pone.0102203-Harman1]--[@pone.0102203-WatsonJones1], [@pone.0102203-Tikhonova1]--[@pone.0102203-Qin2], [@pone.0102203-Li1]--[@pone.0102203-Xu4] were considered eligible in qualitative synthesis. The characteristics of included studies involving 11398 women with syphilis and 43342 women without syphilis and published between 1917 and 2013 were summarized in [Table 1](#pone-0102203-t001){ref-type="table"}. Forty-five studies [@pone.0102203-Liu1]--[@pone.0102203-Qin2], [@pone.0102203-Li1]--[@pone.0102203-Xu4] were conducted in China, one [@pone.0102203-Harman1] in UK, three in USA [@pone.0102203-Wammock1]-[@pone.0102203-Ingraham1], [@pone.0102203-McFarlin1], one [@pone.0102203-Hira1] in Zambia, one [@pone.0102203-McDermott1] in Malawi, one [@pone.0102203-Temmerman1] in Kenya, one [@pone.0102203-WatsonJones1] in Tanzania, and one [@pone.0102203-Tikhonova1] in Russia. All articles belonged to observational studies including retrospective cohort studies, retrospective cases analysis, prospective cohort studies, and prospective surveillance. Twelve studies (21.8%) presented the findings of observational studies that included a "control" arm assessing APOs among women without syphilis. Syphilis prevalence among mothers was reported from 22.1 to 765.7 cases per 10000 pregnant women. Forty-six studies reported on clinical evidence of CS in children. Thirty-four studies reported on preterm birth and fourteen studies reported on low birth weight. Forty-one studies reported on stillbirth or early fetal loss and fifteen studies reported on miscarriage. Twenty studies reported on neonatal death.
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###### Characteristics of studies included in a systematic review and meta-analysis to determine the frequency of adverse pregnancy outcomes (APOs) among women with syphilis and women without syphilis.
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  Study                                                   Location                 Study design           Period     Syphilis prevalence among mothers (1/10000)            Sample size                                                             Subgroup variables                                                                                            Reported adverse pregnancy outcomes (APOs)
  ---------------------------------------------- -------------------------- -------------------------- ------------ --------------------------------------------- ------------------------------- ----------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------
  Harman/1917 [@pone.0102203-Harman1]                  United kingdom          retrospective cohort        1917                         360.0                        Syphilitic mothers: 1001                                            mothers with syphilis or without syphilis                                                                     Congenital syphilis, and stillbirth and fetal loss, and all APOs
                                                                                                                                                                    Non-syphilitic mothers: 826                                                                                                                           
  Wammock/1950 [@pone.0102203-Wammock1]           United states of America     retrospective cohort     1045--1948                      150.0                         Syphilitic mothers: 61                                             mothers with syphilis or without syphilis                                            Congenital syphilis, preterm birth or low birth weight, stillbirth or fetal loss, and neonatal death, and all APOs
                                                                                                                                                                   Non-syphilitic mothers: 5596                                                                                                                           
  Ingraham/1950 [@pone.0102203-Ingraham1]         United states of America      Prospective cohort      1940--1949                      150.0                         Syphilitic mothers: 220                                            mothers with syphilis or without syphilis                                              Congenital syphilis, Stillbirth or fetal loss, neonatal death, preterm birth or low birth weight, and all APOs
                                                                                                                                                                   Non-syphilitic mothers: 10323                                                                                                                          
  Hira/1990 [@pone.0102203-Hira1]                          Zambia            Prospective surveillance   1985--1987                     Unknown                        Syphilitic mothers: 230                                            mothers with syphilis or without syphilis                                                 Congenital syphilis, preterm birth, low birth weight, stillbirth or fetal loss, miscarriage, and all APOs
                                                                                                                                                                   Non-syphilitic mothers: 2647                                                                                                                           
  McDermott/1993 [@pone.0102203-McDermott1]                Malawi              retrospective cohort     1987--1990                      362.0                         Syphilitic mothers: 130                                            mothers with syphilis or without syphilis                                                                        Stillbirth or fetal loss, and neonatal death, and all APOs
                                                                                                                                                                   Non-syphilitic mothers: 3591                                                                                                                           
  Barbara/1995 [@pone.0102203-McFarlin1]          United states of America    Retrospective analysis    1991--1992                     Unknown                        Syphilitic mothers: 253                                            mothers with syphilis or without syphilis                                                                     Congenital syphilis, stillbirth or fetal loss, and neonatal death
                                                                                                                                                                   Non-syphilitic mothers: 7929                                                                                                                           
  Temmerman/2000 [@pone.0102203-Temmerman1]                Kenya                Prospective cohort      1997--1998                      238.4                         Syphilitic mothers: 275                                            mothers with syphilis or without syphilis                                                                              Low birth weight, and stillbirth or fetal loss
                                                                                                                                                                    Non-syphilitic mothers: 275                                                                                                                           
  Deborah WJ/2002 [@pone.0102203-WatsonJones1]            Tanzania              Prospective cohort      1997--1999                      765.7                         Syphilitic mothers: 382      gestational week at treatment; mothers with syphilis or without syphilis; baseline titers of nontreponemal antibodies                            Preterm birth, low birth weight, stillbirth or fetal loss, and all APOs
                                                                                                                                                                    Non-syphilitic mothers: 950                                                                                                                           
  Tikhonova/2003 [@pone.0102203-Tikhonova1]                Russia              retrospective cohort     1995--1999                     Unknown                        Syphilitic mothers: 628                                                        treatment or not                                                                                                      Stillbirth or fetal loss
  Liu JB/2010 [@pone.0102203-Liu1]                     Shenzhen,China           Prospective cohort      2002--2007                      43.4                          Syphilitic mothers: 554                                           baseline titers of nontreponemal antibodies                                                                                           Congenital syphilis
  Zhu LP/2010 [@pone.0102203-Zhu1]                    Shanghai, China           Prospective cohort      2002--2006                      27.5                         Syphilitic mothers: 1471                   treatment or not;baseline titers of nontreponemal antibodies;gestational week at treatment                                                                    Congenital syphilis
  Qin JB/2013 [@pone.0102203-Qin2]                    Shenzhen, China           Prospective cohort      2007--2012                      30.0                          Syphilitic mothers: 360                   treatment or not;baseline titers of nontreponemal antibodies;gestational week at treatment                                                                    Congenital syphilis
  Lv J/2001 [@pone.0102203-Li1]                          Guangzhou            Retrospective analysis    1994--2000                     Unknown                        Syphilitic mothers: 64                                                         treatment or not                                                                             Congenital syphilis, preterm birth, stillbirth or fetal loss, and all APOs
  Xu Y/2001 [@pone.0102203-Xu1]                            Haikou             Retrospective analysis    1995--2001                      62.2                          Syphilitic mothers: 48                                                         treatment or not                                                               Congenital syphilis, preterm birth, stillbirth or fetal loss, miscarriage, neonatal death, and all APOs
  Lin XH/2002 [@pone.0102203-Lin1]                       Guangzhou            Retrospective analysis    1998--2000                      74.0                          Syphilitic mothers: 41                                    treatment or not; mothers with syphilis or without syphilis                                               Congenital syphilis, preterm birth, stillbirth or fetal loss, neonatal death, and all APOs
                                                                                                                                                                   Non-syphilitic mothers: 5532                                                                                                                           
  Fang SN/2003 [@pone.0102203-Fang1]                      Shenzhen            Retrospective analysis    1997--2002                     Unknown                        Syphilitic mothers: 42                                                         treatment or not                                                                       Congenital syphilis, preterm birth, stillbirth or fetal loss, miscarriage, and all APOs
  Wang HB/2003 [@pone.0102203-Wang1]                      Shanghai            Retrospective analysis    1998--2002                      51.2                          Syphilitic mothers: 21                                                         treatment or not                                                                                                         Congenital syphilis
  Kuang YB/2004 [@pone.0102203-Kuang1]                   Guangzhou              Prospective cohort      2001--2003                      135.4                         Syphilitic mothers: 73                                             mothers with syphilis or without syphilis                                                                           Preterm birth, stillbirth or fetal loss, and all APOs
                                                                                                                                                                   Non-syphilitic mothers: 5317                                                                                                                           
  Xu YX/2004 [@pone.0102203-Xu2]                          Shenzhen              Prospective cohort      2002--2003                     Unknown                        Syphilitic mothers: 54                                                         treatment or not                                                                      Congenital syphilis, stillbirth or fetal loss, miscarriage, neonatal death, and all APOs
  Zhang XM/2004 [@pone.0102203-Zhang1]                     Fuzhou               Prospective cohort      1996--2001                      69.7                          Syphilitic mothers: 192                   treatment or not;baseline titers of nontreponemal antibodies;gestational week at treatment                 Congenital syphilis, preterm birth, low birth weight, stillbirth or fetal loss, miscarriage, neonatal death, and all APOs
  Li Q/2005 [@pone.0102203-Li2]                           Dongguan            Retrospective analysis    2003--2004                     Unknown                        Syphilitic mothers: 46                                             mothers with syphilis or without syphilis                                               Congenital syphilis, preterm birth, low birth weight, stillbirth or fetal loss, neonatal death, and all APOs
                                                                                                                                                                    Non-syphilitic mothers: 356                                                                                                                           
  Zhou H/2006 [@pone.0102203-Zhou1]                       Shenzhen              Prospective cohort      2002--2004                      42.9                          Syphilitic mothers: 371                            baseline titers of nontreponemal antibodies;gestational week at treatment                                                                            Congenital syphilis
  Gao H/2006 [@pone.0102203-Gao1]                        Zhanjiang            Retrospective analysis    2002--2005                     Unknown                        Syphilitic mothers: 97                                                   gestational week at treatment                                                             Congenital syphilis, preterm birth, low birth weight, stillbirth or fetal loss, and all APOs
  Wang CX/2006 [@pone.0102203-Wang2]                     Guangzhou            Retrospective analysis    1997--2005                     Unknown                        Syphilitic mothers: 48                                                         treatment or not                                                                       Congenital syphilis, preterm birth, stillbirth or fetal loss, miscarriage, and all APOs
  Xuan QS/2006 [@pone.0102203-Xuan1]                     Guangzhou           prospective surveillance   1995--2003                     Unknown                        Syphilitic mothers: 286                                                  gestational week at treatment                                               Congenital syphilis, preterm birth, low birth weight, stillbirth or fetal loss, miscarriage, neonatal death, and all APOs
  Zheng RQ/2006 [@pone.0102203-Zheng1]                    Shenzhen            Retrospective analysis    2000--2005                      87.0                          Syphilitic mothers: 48                                                         treatment or not                                                               Congenital syphilis, preterm birth, stillbirth or fetal loss, miscarriage, neonatal death, and all APOs
  Wang X/2007 [@pone.0102203-Wang3]                       Shantou             Retrospective analysis     Unknown                       Unknown                        Syphilitic mothers: 68                                                         treatment or not                                                                             Congenital syphilis, preterm birth, stillbirth or fetal loss, and all APOs
  Sun LL/2008 [@pone.0102203-Sun1]                        Shaoguan            Retrospective analysis    2000--2006                      91.7                          Syphilitic mothers: 62                                                         treatment or not                                                                            Congenital syphilis, preterm birth, miscarriage, neonatal death, and all APOs
  Gao JM/2009 [@pone.0102203-Gao2]                        Nanchang           prospective surveillance   2003--2007                     Unknown                        Syphilitic mothers: 82                                                                no                                                                   Congenital syphilis, preterm birth, low birth weight, stillbirth or fetal loss, neonatal death, and all APOs
  Huang ZM/2009 [@pone.0102203-Huang1]                    Shenzhen            Retrospective analysis    2005--2007                     Unknown                        Syphilitic mothers: 452                                  treatment or not;baseline titers of nontreponemal antibodies                                                                                   Congenital syphilis
  Li L/2009 [@pone.0102203-Li3]                           Beijing             Retrospective analysis    2006--2007                     Unknown                        Syphilitic mothers: 121                                         treatment or not;gestational week at treatment                                                              Congenital syphilis, preterm birth, stillbirth or fetal loss, and all APOs
  Wu FY/2009 [@pone.0102203-Wu1]                          Zhejiang            Retrospective analysis    2006--2008                      97.7                          Syphilitic mothers: 47                                                         treatment or not                                                            Congenital syphilis, preterm birth, low birth weight, stillbirth or fetal loss, neonatal death, and all APOs
  Zhou GJ/2009 [@pone.0102203-Zhou2]                       Hefei              Retrospective analysis    2003--2006                      110.3                         Syphilitic mothers: 53                                                         treatment or not                                                            Congenital syphilis, preterm birth, low birth weight, stillbirth or fetal loss, neonatal death, and all APOs
  Chen JH/2010 [@pone.0102203-Chen1]                      Liuyang            prospective surveillance   2008--2009                      77.6                          Syphilitic mothers: 61                                                   gestational week at treatment                                                                Congenital syphilis, preterm birth, stillbirth or fetal loss, miscarriage, and all APOs
  Li TH/2010 [@pone.0102203-Li4]                         Huhehaote           prospective surveillance   2006--2009                     Unknown                        Syphilitic mothers: 168                                         treatment or not;gestational week at treatment                                                              Congenital syphilis, preterm birth, stillbirth or fetal loss, and all APOs
  Shuang JY/2010 [@pone.0102203-Shuang1]                  Taiyuan             Retrospective analysis    2006--2010                     Unknown                        Syphilitic mothers: 48                                   treatment or not;baseline titers of nontreponemal antibodies                                                                            Congenital syphilis, and all APOs
  Ye GR/2010 [@pone.0102203-Ye1]                         Panzhihua              Prospective cohort      2008--2010                     Unknown                        Syphilitic mothers: 80                                                   gestational week at treatment                                                                        Preterm birth, low birth weight, stillbirth or fetal loss, and all APOs
  Dai Y/2011 [@pone.0102203-Dai1]                         Yangzhou            Retrospective analysis    2006--2010                      60.3                          Syphilitic mothers: 136                                                  gestational week at treatment                                                                                           Congenital syphilis, and all APOs
  Li Z/2011 [@pone.0102203-Li5]                           Shenzhen              Prospective cohort      2002--2010                      26.2                          Syphilitic mothers: 427                                                        treatment or not                                                                                                         Congenital syphilis
  Luo ZZ/2011 [@pone.0102203-Luo1]                        Shenzhen              Prospective cohort      2007--2010                      23.7                          Syphilitic mothers: 227                           gestational week at treatment; baseline titers of nontreponemal antibodies                                                                                 All APOs
  Wang WL/2011 [@pone.0102203-Wang4]                      Zhejiang            Retrospective analysis    2006--2009                     Unknown                        Syphilitic mothers: 52                                          treatment or not; gestational week at treatment                                                             Congenital syphilis, preterm birth, stillbirth or fetal loss, and all APOs
  Yuan XQ/2011 [@pone.0102203-Yuan1]                      Chengdu             Retrospective analysis    2010--2011                     Unknown                        Syphilitic mothers: 52                                                   gestational week at treatment                                                                      Congenital syphilis, preterm birth, stillbirth or fetal loss, and all APOs
  Cao DH/2012 [@pone.0102203-Cao1]                       Zhongshan            Retrospective analysis    2005--2010                     Unknown                        Syphilitic mothers: 41                                                         treatment or not                                                      Congenital syphilis, preterm birth, low birth weight, stillbirth or fetal loss, miscarriage, neonatal death, and all APOs
  Chen GJ/2012 [@pone.0102203-Chen2]                      Shenzhen              Prospective cohort      2004--2009                      48.7                          Syphilitic mothers: 330                                                        treatment or not                                                                       Congenital syphilis, preterm birth, stillbirth or fetal loss, miscarriage, and all APOs
  Deng JF/2012 [@pone.0102203-Deng1]                      Shenzhen            Retrospective analysis    2009--2011                     Unknown                        Syphilitic mothers: 58                                                         treatment or not                                                             Congenital syphilis, preterm birth, and stillbirth or fetal loss, miscarriage, neonatal death, and all APOs
  Li HS/2012 [@pone.0102203-Li6]                         Changchun            Retrospective analysis    2006--2011                      22.1                          Syphilitic mothers: 33                                                         treatment or not                                                                                Preterm birth, stillbirth or fetal loss, neonatal death, and all APOs
  Li Z/2012 [@pone.0102203-Li7]                           Chongzuo            Retrospective analysis    2004--2011                     Unknown                        Syphilitic mothers: 86                                                   gestational week at treatment                                                                                           Congenital syphilis, and all APOs
  Pan P/2012 [@pone.0102203-Pan1]                         Shenzhen              Prospective cohort         2005                        Unknown                        Syphilitic mothers: 584                                                               no                                                                                                         Congenital syphilis, and all APOs
  Xu ZY/2012 [@pone.0102203-Xu3]                          Shenzhen              Prospective cohort      2005--2010                     Unknown                        Syphilitic mothers: 772                           gestational week at treatment; baseline titers of nontreponemal antibodies                               Congenital syphilis, preterm birth, low birth weight, stillbirth or fetal loss, neonatal death, and all APOs
  Cui L/2013 [@pone.0102203-Cui1]                         Xinxiang            Retrospective analysis    2007--2012                     Unknown                        Syphilitic mothers: 80                                                         treatment or not                                                                             Congenital syphilis, preterm birth, stillbirth or fetal loss, and all APOs
  Shi J/2013 [@pone.0102203-Shi1]                        Guangzhou            Retrospective analysis    2006--2011                     Unknown                        Syphilitic mothers: 85                                                   gestational week at treatment                                                        Congenital syphilis, preterm birth, stillbirth or fetal loss, miscarriage, neonatal death, and all APOs
  Wei HP/2013 [@pone.0102203-Wei1]                         Beihai               Prospective cohort      2010--2012                     Unknown                        Syphilitic mothers: 89                            gestational week at treatment; baseline titers of nontreponemal antibodies                                          Congenital syphilis, preterm birth, stillbirth or fetal loss, miscarriage, and all APOs
  Wu FY/2013 [@pone.0102203-Wu2]                           Qujing            prospective surveillance   2009--2011                     Unknown                        Syphilitic mothers: 56                                                         treatment or not                                                                             Congenital syphilis, preterm birth, stillbirth or fetal loss, and all APOs
  Xu ZY/2013 [@pone.0102203-Xu4]                          Zhejiang           prospective surveillance   2009--2011                     Unknown                        Syphilitic mothers: 52                                                         treatment or not                                                                         Congenital syphilis, preterm birth, low birth weight, neonatal death, and all APOs

All APOs among women with and without syphilis {#s3b}
----------------------------------------------

The reported proportion range of all APOs in the original studies is from 12.3% to 95.1% with a median of 49.2% among women with syphilis and from 9.3% to 20.8% with a median of 12.5% among women without syphilis ([Table 2](#pone-0102203-t002){ref-type="table"}). The pooled estimates of all APOs were 47.7% (95%CI: 41.6--54.0) among syphilis-infected women and 13.7% (95%CI: 12.0--15.6) among women without syphilis ([Table 2](#pone-0102203-t002){ref-type="table"}), for an absolute difference of 34.0% (χ^2^ = 3616.129, *P* = 0.000) ([Table 3](#pone-0102203-t003){ref-type="table"}). Begg\'s rank correlation test indicated little evidence of publication bias (*P* = 0.171 to 0.397) for summary estimates of all APOs among women with and without syphilis ([Table 2](#pone-0102203-t002){ref-type="table"}). Substantial heterogeneity was found across studies in the estimates of all APOs for both women with syphilis (*I* ^2^ = 93.9%; *P*\<0.0001) and women without syphilis (*I* ^2^ = 94.8%; *P*\<0.0001).

10.1371/journal.pone.0102203.t002

###### Summary estimates of the proportion (%) of adverse pregnancy outcomes (APOs) among women with syphilis and women without syphilis.

![](pone.0102203.t002){#pone-0102203-t002-2}

                               Reported proportion in the original studies           APOs            n     No. of included studies   Summary estimates (95%CI)[\#](#nt102){ref-type="table-fn"}          Heterogeneity               Bias assessment        
  --------------------------- --------------------------------------------- ---------------------- ------ ------------------------- ------------------------------------------------------------ ----------------------------- ---------------------------- -------------
  Women with syphilis                                                                                                                                                                                                                                       
  All APOs                                    12.3%--95.1%                   49.2% (58.0%--37.0%)   2495            5237                                         41                               47.7% (95%CI: 41.6%--54.0%)   I^2^ = 93.9%, *P*\<0.0001    *P* = 0.397
  Congenital syphilis                          0.6%--79.3%                   20.6% (38.2%--10.3%)   1680            9430                                         46                               20.6% (95%CI: 16.4%--25.6%)   I^2^ = 95.3%, *P*\<0.0001    *P* = 0.403
   Preterm birth                               0.9%--39.4%                   15.3% (19.2%--11.0%)   451             4089                                         34                               14.1% (95%CI: 11.4%--17.3%)   I^2^ = 81.6%, *P*\<0.0001    *P* = 0.272
   Low birth weight                            3.6%--29.3%                   17.0% (21.3%--5.8%)    288             2593                                         14                               13.2% (95%CI: 9.2%--18.5%)    I^2^ = 89.3%, *P*\<0.0001    *P* = 0.133
   Miscarriage                                 3.1%--14.8%                    5.6% (10.3%--3.7%)    109             1674                                         15                                6.6% (95%CI: 4.7%--9.3%))    I^2^ = 66.0%, *P = 0.0002*   *P* = 0.194
   Stillbirth or fetal loss                    2.1%--43.8%                   12.1% (21.6%--7.3%)    802             6558                                         41                               12.5% (95%CI: 10.0%--15.5%)   I^2^ = 88.9%, *P*\<0.0001    *P* = 0.391
   Neonatal death                              1.0%--33.3%                    5.5% (13.4%--2.6%)    140             2413                                         20                                6.6% (95%CI: 4.1%--10.4%)    I^2^ = 84.2%, *P*\<0.0001    *P* = 0.107
  Women without syphilis                                                                                                                                                                                                                                    
  All APOs                                     9.3%--20.8%                   12.5% (17.7%--10.9%)   4640            34546                                        9                                13.7% (95%CI: 12.0%--15.6%)   I^2^ = 94.8%, *P*\<0.0001    *P* = 0.171
   Preterm birth                               3.0%--11.8%                    7.6% (9.7%--4.1%)     1201            15011                                        5                                 7.2% (95%CI: 5.6%--9.3%)     I^2^ = 93.6%, *P*\<0.0001    *P* = 0.102
   Low birth weight                            1.8%--9.9%                     5.1% (9.5%--1.9%)     166             4313                                         4                                 4.5% (95%CI: 2.0%--10.0%)    I^2^ = 95.9%, *P*\<0.0001    *P* = 0.142
   Miscarriage                                                                                       62             2647                                         1                                 2.3% (95%CI: 1.8%--3.0%)                                 
   Stillbirth or fetal loss                    1.1%--9.4%                     3.6% (6.4%--1.7%)     1536            42726                                        11                                3.7% (95%CI: 2.6%--5.1%)     I^2^ = 97.3%, *P*\<0.0001    *P* = 0.230
   Neonatal death                              0.8%--4.1%                     2.2% (3.6%--0.8%)     581             27094                                        5                                 2.0% (95%CI: 1.2%--3.3%)     I^2^ = 96.9%, *P*\<0.0001    *P* = 0.181

M = Median; IQR = Inter-quartile range; APOs =  adverse pregnancy outcomes; CI = Confidence interval.

Summary estimates and their corresponding 95% CI were calculated using either fixed-effects models or, in the presence of heterogeneity, random-effects models.

10.1371/journal.pone.0102203.t003

###### Comparison for summary estimates of the proportion (%) of adverse pregnancy outcomes (APOs) among different subgroups.

![](pone.0102203.t003){#pone-0102203-t003-3}

  Subgroup                                                                  All APOs            Congenital syphilis            Preterm birth             Low birth weight                                                                  
  ------------------------------------------------------------------------ ---------- --------------------------------------- --------------- -------------------------------------- ------- ------------------------------------- ------- ------------------------------------
  Women with syphilis *vs* women without syphilis                            34.0%         ?^2^ = 3616.129, *P* = 0.000                                                               6.9%       *χ* ^2^ = 37.312, *P* = 0.000      8.7%      *χ* ^2^ = 138.897, *P* = 0.000
  Untreated women with syphilis *vs* women without syphilis                  63.1%         ?^2^ = 3947.821, *P* = 0.000                                                               16.0%       ?^2^ = 139.350, *P* = 0.000       18.9%      ?^2^ = 110.776, *P* = 0.000
  Treatment in the third trimester *vs* women without syphilis               50.7%          ?^2^ = 727.296, *P* = 0.000                                                               10.4%       ?^2^ = 24.696, *P* = 0.000        7.9%        ?^2^ = 28.440, *P* = 0.000
  High titers (≥1∶8) *vs* women without syphilis                             29.1%          ?^2^ = 209.950, *P* = 0.000                                                               7.9%        ?^2^ = 18.044, *P* = 0.000        4.9%        ?^2^ = 22.790, *P* = 0.000
  Untreated women with syphilis *vs* Treated women with syphilis             52.6%         ?^2^ = 1059.165, *P* = 0.000            22.0%           ?^2^ = 290.433; *P* = 0.000        13.3%      *χ* ^2^ = 66.595, *P* = 0.000      17.2%      *χ* ^2^ = 53.604,*P* = 0.000
  Treatment in the third trimester *vs* treatment in the first trimester     51.1%          ?^2^ = 126.190, *P* = 0.000            31.0%            ?^2^ = 69.475, *P* = 0.000        10.8%      *χ* ^2^ = 8.885, *P* = 0.003       2.4%       *χ* ^2^ = 0.020, *P* = 0.889
  High titers (≥1∶8) *vs* Low titers (\<1∶8)                                 31.8%          ?^2^ = 174.840, *P* = 0.000            21.6%           ?^2^ = 283.664, *P* = 0.000        12.2%      *χ* ^2^ = 55.631, *P* = 0.000      5.5%      *χ* ^2^ = 13.853, *P* = 0.000
  Gestational week at treatment for women with syphilis                                ?^2^ *~trend~* = 140.168, *P* = 0.000                   ?^2^ *~trend~* = 95.126, *P* = 0.000           *χ^2^~trend~* = 12.509, *P* = 0.000           *χ^2^~trend~* = 3.402, *P* = 0.065

Selected APOs among women with and without syphilis {#s3c}
---------------------------------------------------

The pooled estimates were 20.6% (95%CI: 16.4--25.6) for CS, 14.1% (95%CI: 11.4--17.3) for preterm, 13.2% (95%CI: 9.2--18.5) for low birth weight, 12.5% (95%CI: 10.0--15.5) for stillbirth or early fetal loss, 6.6% (95%CI: 4.7--9.3) for miscarriage and 6.6% (95%CI: 4.1--10.4) for neonatal deaths among mothers with syphilis ([Table 2](#pone-0102203-t002){ref-type="table"}). For mothers without syphilis, the pooled estimates were 7.2% (95%CI: 5.6--9.3) for preterm, 4.5% (95%CI:2.0--10.0) for low birth weight, 3.7% (95%CI: 2.6--5.1) for stillbirth or early fetal loss, 2.3% (95%CI: 1.8--3.0) for miscarriage and 2.0% (95%CI: 1.2--3.3) for neonatal deaths ([Table 2](#pone-0102203-t002){ref-type="table"}). The absolute differences between syphilitic mothers and non-syphilitic mothers for preterm birth (*χ* ^2^ = 37.312, *P* = 0.000), low birth weight (*χ* ^2^ = 138.897, *P* = 0.000), stillbirth or fetal loss (*χ* ^2^ = 937.960, *P* = 0.000), miscarriage (*χ* ^2^ = 46.895, *P* = 0.000), and neonatal death (*χ* ^2^ = 124.340, *P* = 0.000) were 6.9%, 8.7%, 8.8%, 4.3%, and 4.6%, respectively ([Table 3](#pone-0102203-t003){ref-type="table"} and [Table 4](#pone-0102203-t004){ref-type="table"}). Begg\'s rank correlation test indicated little evidence of publication bias (*P* = 0.102 to 0.403) for summary estimates of selected APOs among women with and without syphilis ([Table 2](#pone-0102203-t002){ref-type="table"}). Substantial heterogeneity was found across studies in the estimates of selected adverse outcomes for both women with syphilis (*I^2^* range: 66--95.3%; all *P*≤0.0002) and women without syphilis (*I^2^* range: 93.5--97.3%; all *P*\<0.0001).

10.1371/journal.pone.0102203.t004

###### Comparison for summary estimates of the proportion (%) of adverse pregnancy outcomes (APOs) among different subgroups.

![](pone.0102203.t004){#pone-0102203-t004-4}

  Subgroup                                                                  Miscarriage      Stillbirth or fetal loss      Neonatal death                                                
  ------------------------------------------------------------------------ ------------- -------------------------------- ---------------- ------------------------------------- ------- --------------------------------
  Women with syphilis *vs* women without syphilis                              4.3%       *χ* ^2^ = 46.895, *P* = 0.000         8.8%          *χ* ^2^ = 937.960, *P* = 0.000      4.6%    *χ* ^2^ = 124.340, *P* = 0.000
  Untreated women with syphilis *vs* women without syphilis                    12.6%      *χ* ^2^ = 106.857, *P* = 0.000       22.7%           ?^2^ = 2075.991, *P* = 0.000       14.2%   *χ* ^2^ = 415.742, *P* = 0.000
  Treatment in the third trimester *vs* women without syphilis                                                                 17.6%            ?^2^ = 285.499, *P* = 0.000              
  High titers (≥1∶8) *vs* women without syphilis                                                                               10.9%            ?^2^ = 135.901, *P* = 0.000       14.0%   *χ* ^2^ = 214.264, *P* = 0.000
  Untreated women with syphilis *vs* Treated women with syphilis               11.3%      *χ* ^2^ = 42.433, *P* = 0.000        21.9%          *χ* ^2^ = 407.784, *P* = 0.000      13.0%   *χ* ^2^ = 41.721, *P* = 0.000
  Treatment in the third trimester *vs* treatment in the first trimester                                                       16.0%           *χ* ^2^ = 13.714, *P* = 0.000             
  High titers (≥1∶8) *vs* Low titers (\<1∶8)                                                                                   11.9%           *χ* ^2^ = 66.699, *P* = 0.000      15.2%   *χ* ^2^ = 100.451, *P* = 0.000
  Gestational week at treatment for women with syphilis                                                                                     *χ^2^~trend~* = 29.633, *P* = 0.000          

Subgroup analysis {#s3d}
-----------------

The subgroup analysis was performed based on clinical characteristics: treatment or not during pregnancy, gestational week at treatment, and baseline titers of nontreponemal antibodies among women with syphilis for all APOs and selected APOs. After subgroup analysis, the heterogeneity was obviously decreased, although there was still significant heterogeneity for most of subgroups.

"untreated women with syphilis" vs "treated women with syphilis": the pooled estimates were 76.8% (95%CI: 68.8--83.2) for all APOs, 36.0% (95%CI: 28.0--44.9) for CS, 23.2% (95%CI: 18.1--29.3) for preterm, 23.4% (95%CI: 12.8--38.6) for low birth weight, 26.4% (95%CI: 21.9--31.4) for stillbirth or early fetal loss, 14.9% (95%CI: 11.4--19.4) for miscarriage and 16.2% (95%CI: 10.1--25.1) for neonatal deaths among untreated women with syphilis, and in contrast, 24.2% (95%CI: 18.6--30.8) for all APOs, 14.0% (95%CI: 10.5--18.5) for CS, 9.9% (95%CI: 8.6--11.4) for preterm, 6.2% (95%CI: 3.9--9.8) for low birth weight, 4.5% (95%CI: 3.1--6.4) for stillbirth or early fetal loss, 3.6% (95%CI: 2.5--5.1) for miscarriage and 3.2% (95%CI: 1.1--9.1) for neonatal deaths among syphilitic women receiving treatment during pregnancy ([Table 5](#pone-0102203-t005){ref-type="table"}), for the absolute differences of 52.6%, 22.0%, 13.3%, 17.2%, 21.9%, 11.3%, and 13.0% (all *P* value = 0.0000), respectively ([Table 3](#pone-0102203-t003){ref-type="table"} and [Table 4](#pone-0102203-t004){ref-type="table"}). Begg\'s rank correlation test indicated little evidence of publication bias (*P* = 0.102 to 0.353) for summary estimates of APOs among untreated and treated women with syphilis ([Table 5](#pone-0102203-t005){ref-type="table"}). Compared with women without syphilis, the untreated women with syphilis had significantly higher proportions of pregnancy loss, and the absolute differences were 63.1% for all APOs (χ^2^ = 3947.821, *P* = 0.000), 16.0% for preterm (χ^2^ = 139.350, *P* = 0.000), 18.9% for low birth weight (χ^2^ = 110.776, *P* = 0.000), 22.7% for stillbirth or early fetal loss (χ^2^ = 2075.991, *P* = 0.000), 12.6% for miscarriage (*χ* ^2^ = 106.857, *P* = 0.000) and 14.2% for neonatal deaths (*χ* ^2^ = 415.742, *P* = 0.000) ([Table 3](#pone-0102203-t003){ref-type="table"} and [Table 4](#pone-0102203-t004){ref-type="table"}).

10.1371/journal.pone.0102203.t005

###### Subgroup analysis based on treatment or not in pregnancy for the proportion (%) of adverse pregnancy outcomes (APOs) among syphilis-infected women.

![](pone.0102203.t005){#pone-0102203-t005-5}

  Treatment or not in pregnancy                                   Reported proportion in the original studies           APOs            n     No. of included studies   Summary estimates (95%CI)[\#](#nt104){ref-type="table-fn"}          Heterogeneity               Bias assessment        
  -------------------------------------------------------------- --------------------------------------------- ---------------------- ------ ------------------------- ------------------------------------------------------------ ----------------------------- ---------------------------- -------------
  Untreated women with syphilis                                                                                                                                                                                                                                                                
  All APOs                                                                       13.9%--100.0%                  82.7% (89.5%--70.4%)   1611            2651                                         32                               76.8% (95%CI: 68.8%--83.2%)   I^2^ = 92.7%, *P*\<0.0001    *P* = 0.207
  Congenital syphilis                                                             2.2%--81.8%                   34.4% (68.3%--23.7%)   887             3240                                         33                               36.0% (95%CI: 28.0%--44.9%)   I^2^ = 92.9%, *P*\<0.0001     P = 0.117
   Preterm birth                                                                  3.0%--62.5%                   18.2% (28.7%--12.6%)   179              932                                         25                               23.2% (95%CI: 18.1%--29.3%)    I^2^ = 6.6%, *P*\<0.0001    *P* = 0.102
   Low birth weight                                                               6.8%--50.0%                   29.6% (32.0%--11.3%)    63              403                                         8                                23.4% (95%CI: 12.8%--38.6%)   I^2^ = 81.3%, *P*\<0.0001    *P* = 0.104
   Miscarriage                                                                    6.1%--29.4%                   16.0% (20.0%--7.9%)     46              343                                         10                               14.9% (95%CI: 11.4%--19.4%)   I^2^ = 26.4%, *P* = 0.2012   *P* = 0.172
   Stillbirth or fetal loss                                                       7.1%--66.7%                   25.0% (42.1%--17.2%)   660             3001                                         31                               26.4% (95%CI: 21.9%--31.4%)   I^2^ = 81.8%, *P*\<0.0001    *P* = 0.202
   Neonatal death                                                                 1.3%--60.0%                   15.2% (25.9%--7.4%)    117              910                                         16                               16.2% (95%CI: 10.1%--25.1%)   I^2^ = 81.5%, *P*\<0.0001    *P* = 0.212
  Treated women with syphilis[\*](#nt105){ref-type="table-fn"}                                                                                                                                                                                                                                 
  All APOs                                                                        2.4%--54.4%                   24.5% (38.2%--15.9%)   767             3711                                         36                               24.2% (95%CI: 18.6%--30.8%)   I^2^ = 92.5%, *P*\<0.0001    *P* = 0.353
  Congenital syphilis                                                             0.7%--50.8%                   13.9% (21.9%--8.2%)    621             4975                                         35                               14.0% (95%CI: 10.5%--18.5%)   I^2^ = 91.1%, *P*\<0.0001    *P* = 0.303
  Preterm birth                                                                   4.7%--23.3%                   14.6% (32.6%--6.0%)    180             2060                                         28                                9.9% (95%CI: 8.6%--11.4%)    I^2^ = 43.1%, *P* = 0.0089   *P* = 0.170
  Low birth weight                                                                2.2%--15.3%                    6.3% (10.7%--2.3%)     72             1457                                         10                                6.2% (95%CI: 3.9%--9.8%)     I^2^ = 70.4%, *P* = 0.0004   *P* = 0.139
  Miscarriage                                                                     2.1%--6.2%                     4.0% (5.6%--3.2%)      29              862                                         7                                 3.6% (95%CI: 2.5%--5.1%)      I^2^ = 0%, *P* = 0.6896     *P* = 0.107
  Stillbirth or fetal loss                                                        1.1%--13.5%                    3.4% (8.6%--2.0%)      98             2661                                         24                                4.5% (95%CI: 3.1%--6.4%)     I^2^ = 58.5%, *P* = 0.0002   *P* = 0.219
  Neonatal death                                                                  1.0%--10.3%                    4.6% (8.1%--1.1%)      9               446                                         5                                 3.2% (95%CI: 1.1%--9.1%)     I^2^ = 59.0%, *P* = 0.0449   *P* = 0.111

M = Median; IQR = Inter-quartile range; APOs =  adverse pregnancy outcomes; CI = Confidence interval.

Summary estimates and their corresponding 95% CI were calculated using either fixed-effects models or, in the presence of heterogeneity, random-effects models.

\*Syphilitic women receiving at least one injection of 2.4 million units of penicillin before delivery.

"treatment in the third trimester" vs "treatment in the first trimester": the pooled estimates of all APOs, CS, preterm, low birth weight, and stillbirth or early fetal loss were 64.4% (95%CI: 45.2--79.8), 40.6% (95%CI: 31.3--50.7), 17.6% (95%CI: 11.4--26.5), 12.4% (95%CI: 5.9--24.2), and 21.3% (95%CI: 17.2--26.0), respectively among women with syphilis receiving treatment in the third trimester (i.e.\>28 weeks), and 13.3% (95%CI: 7.7--21.8), 10.4% (95%CI: 7.7--14.0), 6.8% (95%CI: 3.7--12.2), 10.0% (95%CI: 2.5--32.4), and 5.3% (95%CI: 2.2--12.1), respectively among syphilitic women who got treatment in the first trimester (i.e.≤12 weeks) ([Table 6](#pone-0102203-t006){ref-type="table"}), for the absolute differences of 51.1% (*P* = 0.000), 31.1% (*P* = 0.000), 10.8% (*P* = 0.003), 2.4% (*P* = 0.889), and 16.0% (*P* = 0.000), respectively ([Table 3](#pone-0102203-t003){ref-type="table"} and [Table 4](#pone-0102203-t004){ref-type="table"}). Begg\'s rank correlation test indicated little evidence of publication bias (*P* = 0.101 to 0.134) for summary estimates of APOs among women with syphilis according to gestational week at treatment ([Table 6](#pone-0102203-t006){ref-type="table"}). Compared with non-syphilitic women ([Table 3](#pone-0102203-t003){ref-type="table"} and [Table 4](#pone-0102203-t004){ref-type="table"}), the syphilis-infected women who received treatment in the third trimester also had evidently increased proportions of adverse outcomes, and the absolute differences were 50.7% for all APOs (χ^2^ = 727.296, *P* = 0.000), 10.4% for preterm (χ^2^ = 24.696, *P* = 0.000), 7.9% for low birth weight (χ^2^ = 28.440, *P* = 0.000), and 17.6% for stillbirth or early fetal loss (χ^2^ = 285.499, *P* = 0.000).

10.1371/journal.pone.0102203.t006

###### Subgroup analysis based on gestational week at treatment for the proportion (%) of adverse pregnancy outcomes (APOs) among syphilis-infected women.

![](pone.0102203.t006){#pone-0102203-t006-6}

  Gestational week at treatment                       Reported proportion in the original studies           APOs            n    No. of included studies   Summary estimates (95%CI)[\#](#nt107){ref-type="table-fn"}          Heterogeneity               Bias assessment        
  -------------------------------------------------- --------------------------------------------- ---------------------- ----- ------------------------- ------------------------------------------------------------ ----------------------------- ---------------------------- -------------
  Treatment in the first trimester (≤12 weeks)                                                                                                                                                                                                                                    
  All APOs                                                            6.5%--36.0%                    8.2% (20.6%--6.8%)    37              277                                         8                                13.3% (95%CI: 7.7%--21.8%)    I^2^ = 59.8%, *P* = 0.0149   *P* = 0.114
  Congenital syphilis                                                 2.9%--20.8%                    8.2% (9.4%--5.4%)     39              416                                         8                                10.4% (95%CI: 7.7%--14.0%)    I^2^ = 32.8%, *P* = 0.1662   *P* = 0.105
   Preterm birth                                                      2.8%--12.0%                    6.5% (11.0%--3.5%)    10              172                                         5                                 6.8% (95%CI: 3.7%--12.2%)     I^2^ = 0%, *P* = 0.5053     *P* = 0.110
   Low birth weight                                                                                                         2              20                                          1                                10.0% (95%CI: 2.5%--32.4%)                                
   Stillbirth or fetal loss                                           4.1%--8.0%                            6.1%            5              99                                          2                                 5.3% (95%CI: 2.2%--12.1%)     I^2^ = 0%, *P* = 0.4445    
  Treatment in the second trimester (12--28 weeks)                                                                                                                                                                                                                                
  All APOs                                                            15.6%--65.1                   40.0% (63.6%--22.6%)   138             447                                         7                                   37.8% (23.7%--54.3%)       I^2^ = 88.7%, *P*\<0.0001    *P* = 0.102
   Congenital syphilis                                                3.2%--44.7%                   19.1% (27.8%--8.7%)    249            1359                                         13                               17.6% (95%CI: 11.8%--25.4%)   I^2^ = 84.1%, *P*\<0.0001    *P* = 0.114
   Preterm birth                                                      2.5%--25.0%                    9.7% (19.6%--6.0%)    32              379                                         5                                10.1% (95%CI: 5.2%--18.5%)     I^2^ = 65%, *P* = 0.0220    *P* = 0.101
   Low birth weight                                                   1.7%--15.0%                                           5              140                                         2                                 5.3% (95%CI: 0.6%--35.8%)    I^2^ = 83.6%, *P* = 0.0136  
   Stillbirth or fetal loss                                           1.7%--7.1%                            6.5%            6              179                                         3                                 4.2% (95%CI: 1.9%--9.1%)     I^2^ = 27.2%, *P* = 0.2522   *P* = 0.103
  Ttreatment in the third trimester (\>28 weeks)                                                                                                                                                                                                                                  
  All APOs                                                           12.0%--100.0%                  68.2% (94.4%--34.5%)   292             540                                         11                               64.4% (95%CI: 45.2%--79.8%)   I^2^ = 91.6%, *P*\<0.0001    *P* = 0.116
   Congenital syphilis                                               18.2%--83.3%                   45.0% (60.0%--26.5%)   428            1454                                         15                               40.6% (95%CI: 31.3%--50.7%)    I^2^ = 87%, *P*\<0.0001     *P* = 0.131
   Preterm birth                                                      5.3%--35.0%                   20.6% (26.9%--12.9%)   65              447                                         7                                17.6% (95%CI: 11.4%--26.5%)   I^2^ = 69.2%, *P* = 0.0035   *P* = 0.134
   Low birth weight                                                   3.4%--26.9%                   12.8% (23.9%--5.2%)    26              236                                         4                                12.4% (95%CI: 5.9%--24.2%)    I^2^ = 66.1%, *P* = 0.0315   *P* = 0.101
   Stillbirth or fetal loss                                          17.7%--40.0%                   22.9% (27.7%--18.9%)   71              336                                         6                                21.3% (95%CI: 17.2%--26.0%)    I^2^ = 0%, *P* = 0.8177     *P* = 0.107

M = Median; IQR = Inter-quartile range; APOs =  adverse pregnancy outcomes; CI = Confidence interval.

Summary estimates and their corresponding 95% CI were calculated using either fixed-effects models or, in the presence of heterogeneity, random-effects models.

"high titers" vs "low titers": the pooled estimates were 42.8% (95%CI: 26.2--61.2) for all APOs, 25.8% (95%CI: 15.4--40.1) for CS, 15.1% (95%CI: 5.2--36.9) for preterm, 9.4% (95%CI: 2.7--27.5) for low birth weight, 14.6% (95%CI: 6.5--29.7) for stillbirth or early fetal loss and 16.0% (95%CI: 12.0--21.1) for neonatal deaths among syphilitic women with high titers, and 11.0% (95%CI: 6.3--18.5) for all APOs, 4.2% (95%CI: 1.9--9.1) for CS, 2.9% (95%CI: 0.8--10.2) for preterm, 3.9% (95%CI: 2.7--5.5) for low birth weight, 2.7% (95%CI: 0.4--15.3) for stillbirth or early fetal loss and 0.8% (95%CI: 0.1--10.2) for neonatal deaths among syphilitic women with low titers ([Table 7](#pone-0102203-t007){ref-type="table"}), for the absolute differences of 31.8% (χ^2^ = 174.840, *P* = 0.000), 21.6% (χ^2^ = 283.664, *P* = 0.000), 12.2% (*χ* ^2^ = 55.631, *P* = 0.000), 5.5% (*χ* ^2^ = 13.853, *P* = 0.000), 11.9% (*χ* ^2^ = 66.699, *P* = 0.000), and 15.2% (*χ* ^2^ = 100.451, *P* = 0.000), respectively ([Table 3](#pone-0102203-t003){ref-type="table"} and [Table 4](#pone-0102203-t004){ref-type="table"}). Begg\'s rank correlation test indicated little evidence of publication bias (*P* = 0.102 to 0.210) for summary estimates of APOs among women with syphilis according to baseline titers of nontreponemal antibodies ([Table 7](#pone-0102203-t007){ref-type="table"}).Similarly, when compared with women without syphilis, the syphilitic women with high titers also had significantly higher proportions of all APOs (all *P* value = 0.0000), preterm, low birth weight, stillbirth or early fetal loss as well as neonatal deaths, and the absolute differences were 29%, 8%, 4%, 13%, and 14%, respectively ([Table 3](#pone-0102203-t003){ref-type="table"} and [Table 4](#pone-0102203-t004){ref-type="table"}).

10.1371/journal.pone.0102203.t007

###### Subgroup analysis based on baseline titers of nontreponemal antibodies for the proportion (%) of adverse pregnancy outcomes (APOs) among syphilis-infected women.

![](pone.0102203.t007){#pone-0102203-t007-7}

  Maternal baseline titers of nontreponemal antibodies    Reported proportion in the original studies           APOs            n    No. of included studies   Summary estimates (95%CI)[\#](#nt109){ref-type="table-fn"}          Heterogeneity               Bias assessment        
  ------------------------------------------------------ --------------------------------------------- ---------------------- ----- ------------------------- ------------------------------------------------------------ ----------------------------- ---------------------------- -------------
  Low titers (\<1∶8)                                                                                                                                                                                                                                                                  
  All APOs                                                                3.7%--24.1%                    9.3% (21.9%--4.9%)    114            1215                                         6                                11.0% (95%CI: 6.3%--18.5%)     I^2^ = 87%, *P*\<0.0001     *P* = 0.131
  Congenital syphilis                                                     0.2%--21.9%                    4.1% (14.0%--1.3%)    251            3085                                         8                                 4.2% (95%CI: 1.9%--9.1%)     I^2^ = 94.4%, *P*\<0.0001    *P* = 0.210
   Preterm birth                                                          0.5%--9.3%                     3.6% (8.3%--0.9%)     32              998                                         3                                 2.9% (95%CI: 0.8%--10.2%)     I^2^ = 88%, *P*\<0.0001     *P* = 0.130
   Low birth weight                                                       3.4%--5.2%                            3.7%           31              813                                         3                                 3.9% (95%CI: 2.7%--5.5%)      I^2^ = 0%, *P* = 0.5164     *P* = 0.127
   Stillbirth or fetal loss                                               0.7%--7.8%                            3.7%           20              813                                         3                                 2.7% (95%CI: 0.4%--15.3%)    I^2^ = 89.9%, *P*\<0.0001    *P* = 0.102
   Neonatal death                                                         0.2%--2.6%                            1.4%            4              708                                         2                                 0.8% (95%CI: 0.1%--10.2%)    I^2^ = 82.5%, *P* = 0.0167  
  High titers (≥1∶8)                                                                                                                                                                                                                                                                  
  All APOs                                                               15.2%--73.7%                   49.3% (63.9%--21.9%)   182             510                                         6                                42.8% (95%CI: 26.2%--61.2%)   I^2^ = 92.2%, *P*\<0.0001    *P* = 0.111
  Congenital syphilis                                                     2.2%--72.2%                   25.2% (40.7%--15.8%)   325            1161                                         8                                25.8% (95%CI: 15.4%--40.1%)   I^2^ = 94.4%, *P*\<0.0001    *P* = 0.152
   Preterm birth                                                          2.2%--37.5%                   20.0% (34.4%--5.5%)    51              359                                         3                                15.1% (95%CI: 5.2%--36.9%)    I^2^ = 91.8%, *P*\<0.0001    *P* = 0.112
   Low birth weight                                                       4.5%--24.7%                           6.3%           32              347                                         3                                 9.4% (95%CI: 2.7%--27.5%)    I^2^ = 90.9%, *P*\<0.0001    *P* = 0.105
   Stillbirth or fetal loss                                               6.2%--34.2%                   12.8% (29.2%--7.6%)    57              383                                         3                                14.6% (95%CI: 6.5%--29.7%)     I^2^ = 88%, *P*\<0.0001     *P* = 0.105
   Neonatal death                                                        15.2%--18.1%                          16.7%           40              250                                         2                                16.0% (95%CI: 12.0%--21.1%)    I^2^ = 0%, *P* = 0.5733    

M = Median; IQR = Inter-quartile range; APOs =  adverse pregnancy outcomes; CI = Confidence interval.

Summary estimates and their corresponding 95% CI were calculated using either fixed-effects models or, in the presence of heterogeneity, random-effects models.

Discussion {#s4}
==========

In the present study, we quantified the proportion of all APOs and specific APOs among syphilis-infected women and non-syphilitic women using data from fifty-four studies that met eligibility criteria for inclusion in our systematic review and meta-analysis and involved 11398 women with syphilis and 43342 women without syphilis. In the context of WHO\'s global initiative for the elimination of CS and National Program for Prevention and Control of Syphilis in China (2010--2020), this study could supply helpful information to both clinical doctors and infected mothers, and help to assess progress in elimination of MTCT of syphilis and to guide policy and advocacy efforts. To our knowledge, this is the first time that the epidemic of APOs among women with syphilis was exhaustively reviewed based on clinical features by meta-analysis.

Findings from present study further confirmed the ancient tune that MTCT of syphilis undoubtedly brings about a heavy burden to society. Notwithstanding being easily detectable and treatable in pregnancy, presently, syphilis remains an important cause of birth loss [@pone.0102203-Qin1], [@pone.0102203-WatsonJones2], [@pone.0102203-Qin2]. On average, our review showed that APOs accounted for significantly higher proportions among the offspring of syphilis-infected mothers than among the offspring of mothers without syphilis, especially among syphilis-infected women who didn\'t receive treatment during pregnancy, or who did not receive treatment until the third trimester, or who had high baseline titers.

Previous studies have confirmed that lack of treatment or postponement of gestational week for first treatment and high baseline titers were independent risk factors of APOs among syphilitic mothers [@pone.0102203-Qin1], [@pone.0102203-Deperthes1]. Our study indicates that, unless testing and treatment of syphilis in pregnancy are universally available, over half of pregnancies in women with syphilis will result in an adverse outcome. In general, our estimates are consistent with previously published data. In order to block MTCT of syphilis and support the global initiative for elimination of CS, WHO has developed 2008 worldwide estimates of maternal syphilis and associated APOs, which indicated that, globally, 520,905 adverse outcomes were estimated to be caused by maternal syphilis, including approximately 212,327 stillbirths or early fetal deaths, 91,764 neonatal deaths, 65,267 preterm or low birth weight infants, and 151,547 infected newborns [@pone.0102203-Newman1]. Furthermore, WHO also revealed that approximately 66% of adverse outcomes occurred in antenatal care (ANC) attendees who were not tested or were not treated for syphilis, and in 2008, based on the middle case scenario, clinical services likely averted 26% of all APOs [@pone.0102203-Newman1]. The latest meta-analysis by Gomez et al. [@pone.0102203-Gomez1] showed that approximately 52% of pregnancies in mothers with untreated or inadequately treated syphilis result in some APOs, with estimated proportions: early fetal loss or stillbirth (21%), neonatal death (9%), low birth weight or premature birth (6%), and infection in a live-born infant (15%). Berman [@pone.0102203-Berman1] indicated that if left untreated, maternal syphilis infection will, in up to 80% of pregnancies, lead to severely APOs, including stillbirth, premature birth, neonatal death, or congenital infection in the newborn. Qin JB et al. [@pone.0102203-Qin1] confirmed that for mothers who did not receive complete treatment during pregnancy, 18.5% delivered an infant with CS and 48.1% resulted in APOs. It has been estimated that the numbers of fetal/neonatal deaths in Africa each year from untreated maternal syphilis could rival those from HIV infections [@pone.0102203-Gloyd1].

Both previous studies and present review indicated that improving quality of ANC is a key point to eliminate MTCT of syphilis and reduce the risk of APOs among women with syphilis. This highlights the importance of absent or insufficient ANC as an independent risk factor for pregnancy loss among syphilis-infected mothers. ANC is not only the best opportunity to treat maternal syphilis, but it is also important for the control of a woman who had received documented adequate treatment for syphilis before pregnancy, and is necessary for the interpretation of a positive serologic test at delivery [@pone.0102203-Lago1]. Screening and treatment of syphilis during pregnancy is considered to be simple, cheap, and highly cost-effective in prevention of MTCT of syphilis. For these reasons, screening pregnant women during their first ANC is recommended by the WHO [@pone.0102203-Saloojee1]. However, presently, approximately one-fifth (20%) of all pregnant women with syphilis did not attend ANC [@pone.0102203-Newman1]. It is also recognized that the effectiveness of screening and treatment is lower in the third trimester than in the first and second trimesters [@pone.0102203-Hawkes2]. Given that screening and treatment for preventing MTCT of syphilis is not 100% effective, primary prevention of syphilis in pregnant women is also an important strategy that needs to be addressed to truly eliminate MTCT of syphilis. Although substantial progress has been made in the utilization of ANC (in 2009 WHO estimated that approximately 81% of all pregnant women had attended at least one ANC visit [@pone.0102203-Newman1]), MTCT of syphilis occurred for a variety of reasons: many of these visits were too late to avert an adverse outcome, clinics may not have offered testing, testing may not have been affordable, women may not have followed up or received their test results, treatment may not have been available, or treated women may have been reinfected by untreated sexual partners [@pone.0102203-Kamb1].

Our estimates are subject to certain limitations that should be considered when interpreting the results. Firstly, all studies included in our review had an observational design, and most belonged to a retrospective cases analysis. Owing to the inherent differences between experimental and observational study designs and to biases commonly seen in observational data, appropriate caution should be taken in interpreting our results. Nevertheless, an advantage of this review is that we included a comparison group to assess APOs among mothers without syphilis. This gave us the opportunity to estimate the excess adverse outcomes in the presence of maternal syphilis and give a broad idea of the risk of some of the pregnancy loss in syphilis-infected women. Secondly, there was also unacceptable heterogeneity in estimates across studies. We tried to find the sources of heterogeneity by subgroup analysis. After subgroup analysis, the heterogeneity was obviously decreased. However, our estimates have to be viewed with caution because of heterogeneity. Thirdly, because variations in the definition of APOs exist across countries and cultures, it is extremely difficult to define uniform standards. The early literatures did not always define birth outcomes and in such cases we relied on the outcome terminology in the original papers. So the misclassification of APOs may influence the results. Last but not least, our relatively strict inclusion criteria might have introduced selection bias. In present analysis, we only included studies published in Chinese or English language. So the additional research in other populations is warranted to generalize the findings. The limitations of these estimates highlight the urgent need for improved data through stronger national surveillance and monitoring systems.

In summary, present study indicates that syphilis continues to be an important cause of substantial numbers of perinatal deaths and disabilities that could be prevented by early testing and treatment, and also reminds policy-makers charged with resource allocation that the elimination of MTCT of syphilis is a public health priority. Most adverse outcomes occurred among women who were not treated for syphilis or who receiving treatment only in the late trimester or who had high baseline titers. High quality of ANC highlighting early testing and treatment is the only effective means to block MTCT of syphilis. Health education for pregnant women should continue to reinforce the message that untreated maternal syphilis is a danger to the unborn infant, that syphilis can be diagnosed and treated, and that women should attend an antenatal that can perform syphilis screening as soon as they suspect that they are pregnant. Systematic attention to testing, treatment, education, and contact tracing in pregnancy and subsequent late trimester retesting of women at high risk will lower pregnancy loss.
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